Related Experiment Video
Updated: Aug 14, 2026

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
Emerging neurotropic features of SARS-CoV-2
Wen-Rong Zhan1, Jing Huang1, Peng-Ming Zeng1
1School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Abstract:
The prevailing coronavirus disease-19 (COVID-19) caused by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has presented some neurological manifestations including hyposmia, hypogeusia, headache, stroke, encephalitis, Guillain-Barre syndrome, and some neuropsychiatric disorders. Although several cell types in the brain express angiotensin-converting enzyme-2 (ACE2), the main SARS-CoV-2 receptor, and other related proteins, it remains unclear whether the observed neurological manifestations are attributed to virus invasion into the brain or just comorbidities caused by dysregulation of systemic factors. Here, we briefly review the neurological manifestations of SARS-CoV-2, summarize recent evidence for the potential neurotropism of SARS-CoV-2, and discuss the potential mechanisms of COVID-19-associated neurological diseases.
Related Concept Videos
Rabies
Arboviral Encephalitis
Coronavirus
Respiratory Syncytial Virus Disease
Encephalitis ll: Pathophysiology

